Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers

Sophie Paczesny; Marcelo C. Pasquini; Steven Z. Pavletic; Amit Agarwal; Stephen Spellman; Leslie Kean; Chantale Bernatchez; Juliane Gust; Verena Staedtke; Miguel Angel Perales

doi:10.1182/BLOODADVANCES.2021004604

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers

Sophie Paczesny, Marcelo C. Pasquini, Steven Z. Pavletic, Amit Agarwal, Stephen Spellman, Leslie Kean, Chantale Bernatchez, Juliane Gust, Verena Staedtke, Miguel Angel Perales

Melanoma Medical Oncology

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	2519-2522
Number of pages	4
Journal	Blood Advances
Volume	5
Issue number	11
DOIs	https://doi.org/10.1182/BLOODADVANCES.2021004604
State	Published - Jun 8 2021

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/BLOODADVANCES.2021004604

Cite this

@article{5a0c10865f0545b7b1d0341f49916e75,

title = "Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers",

author = "Sophie Paczesny and Pasquini, {Marcelo C.} and Pavletic, {Steven Z.} and Amit Agarwal and Stephen Spellman and Leslie Kean and Chantale Bernatchez and Juliane Gust and Verena Staedtke and Perales, {Miguel Angel}",

note = "Funding Information: Acknowledgments: The authors thank the ASH Task Force on Immunotherapies for organizing this workshop (see collaborators in the supplemental Appendix). The authors also thank Jennifer Motl, free-lance medical writer (Milwaukee, WI), for editorial support, funded by ASH (Washington, DC), according to Good Publication Practice. Funding Information: The CIDR at the Center for International Blood and Marrow Transplant Research is supported by National Cancer Institute, National Institutes of Health, grant U24CA233032.",

year = "2021",

month = jun,

day = "8",

doi = "10.1182/BLOODADVANCES.2021004604",

language = "English (US)",

volume = "5",

pages = "2519--2522",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers

AU - Paczesny, Sophie

AU - Pasquini, Marcelo C.

AU - Pavletic, Steven Z.

AU - Agarwal, Amit

AU - Spellman, Stephen

AU - Kean, Leslie

AU - Bernatchez, Chantale

AU - Gust, Juliane

AU - Staedtke, Verena

AU - Perales, Miguel Angel

N1 - Funding Information: Acknowledgments: The authors thank the ASH Task Force on Immunotherapies for organizing this workshop (see collaborators in the supplemental Appendix). The authors also thank Jennifer Motl, free-lance medical writer (Milwaukee, WI), for editorial support, funded by ASH (Washington, DC), according to Good Publication Practice. Funding Information: The CIDR at the Center for International Blood and Marrow Transplant Research is supported by National Cancer Institute, National Institutes of Health, grant U24CA233032.

PY - 2021/6/8

Y1 - 2021/6/8

UR - http://www.scopus.com/inward/record.url?scp=85108351661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108351661&partnerID=8YFLogxK

U2 - 10.1182/BLOODADVANCES.2021004604

DO - 10.1182/BLOODADVANCES.2021004604

M3 - Letter

C2 - 34100901

AN - SCOPUS:85108351661

SN - 2473-9529

VL - 5

SP - 2519

EP - 2522

JO - Blood Advances

JF - Blood Advances

IS - 11

ER -

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this